A novel inhibitor of angiotensin I converting enzyme (ACE), designated K-26, was isolated from the broth filtrate of an actiomycete K-26. K-26 is a water soluble, acidic peptide composed of an equal mol of L-isoleucine, L-tyrosine and l(R)-l-amino-2-(4-hydroxyphenyl)-ethylphosphonic acid. The IC50 of K-26 for ACE inhibition was 6.7 ng/ml when hippuryl-Lhistidyl-L-leucine was used as a substrate of ACE. K-26 possesses hypotensive activity in vivo.
Assay of ACE Inhibitory Activity ACE activity was assayed in the presence or absence of an inhibitor by the method of CUSHMAN and CHEUNG5), HHL being used as a substrate, or by that of CHEUNG and CUSHMAN7) when angiotensin I (AG I) was used as a substrate. ICS, was defined as the concentration at which ACE activity was inhibited by 50%.
Assay of Other Proteases
Pancreatic carboxypeptidase A, a-chymotrypsin and trypsin were assayed spectrophotometrically by hydrolysis of hippuryl-L-phenylalanine8), N-benzoyl-L-tyrosine ethyl ester (BTEE)9) and p-toluenesulfonyl-L-arginine methyl ester (TAME)9), respectively. Carboxypeptidase B was assayed likewise by hydrolysis of hippuryl-L-arginine10).
Culture and Medium Conditions
The producing organism, an actinomycete K-26 (FERM-P 5859, NRRL 12379), was recently isolated from a soil sample of the bank at Kadoike in Numazu City, Shizuoka Prefecture. K-26 was produced also by Micromonospora sp. strain K-24 (FERM-P 7031). The strain K-26 was used in this study. Morphological, cultural and physiological characteristics of the strains will be described in detail elsewhere. The seed medium consisted of glucose 1%, soluble starch 1 %, beef extract 0.5 %, yeast extract 0.5%, Bacto Tryptone 0.5% and CaCO3 0.2%, pH 7.2. The production medium consisted of soluble starch 4%, soy bean meal (SBM) 3%, corn steep liquor (CSL) 0.5%, K,HPO, 0.05%, MgSO4 • 7H2O 0.05 %, KCl 0.03 % and CaCO3 0.3 %, pH 7.8.
Ten milliliters of seed medium in a 50-ml test tube was inoculated with a loopful of microorganism grown on the surface of an agar slant. The test tube was then incubated for 10 to 12 days at 28°C on a reciprocal shaker. Three milliliters of this culture was transferred into a 300-m1 flask containing 30 ml of seed medium. The flask was then incubated for 3 to 4 days at 28°C on a rotary shaker (220 rpm). Five milliliters of this seed culture was transferred into a 300-m1 flask containing 50 ml of production medium. The flask was then incubated for 5 days at 28°C on a rotary shaker (220 rpm). When a jar fermentor was employed in the production of K-26, 10 ml of the seed culture incubated in a 50-ml test tube for 10 to 12 days at 28°C was transferred into a 2-liter flask containing 300 ml of seed medium. The flask was incubated for 3 to 4 days at 28°C on a rotary shaker (220 rpm). The seed culture in three flasks was combined and transferred into a 30-liter jar fermentor containing 15 liters of production medium. The fermentor was operated for 5 days at 30°C with agitation at 350 rpm and aeration of 15 liters/minute. The growth was monitored by packed cell volume (PCV). The production of K-26 was traced by measuring ACE inhibitory activity of the broth filtrate as described above.
Measurement of Pressor Responses to Angiotensin I, Angiotensin II and Noradrenaline in Anesthetized Rats
Male Wister strain rats weighing 200 to 250 g were used. All rats were anesthetized by intraperitoneal administration of urethane at 500 mg/kg and a-chloralose at 50 mg/kg. Carotid artery and femoral vein were cannulated with polyethylene tubings. The arterial canula was connected to a pressure transducer (MPV-0.5, Nihon Kohden), and the blood pressure was recorded on polygraph (RM-45, Nihon Kohden). Drugs were dissolved in saline, and injected into the venous canula.
Materials
Peptides and amino acid derivatives were purchased from the following commercial sources: HHL, BTEE and TAME from Calbiochem; hippuryl-L-arginine and hippwyl-L-phenylalanine from Sigma Chemical Corp. ; AG I from Protein Res. Foundation, Osaka, Japan. Rabbit lung acetone powder was obtained from Pel-Freez Biologicals; carboxypeptidase A, thermolysin, pronase E, papain type II, pepsin and subtilisin BPN' from Sigma Chemical Corp.; carboxypeptidase B and leucine aminopeptidase from Boehringer-Mannheim; trypsin and a-chymotrypsin from Worthington Biochemical Corp. Other chemicals were reagent grade and commercially available. JAN. 1986 Results
Production of K-26 by Fermentation
A time course of K-26 production by the producing organism in a 30-liter jar fermentor is represented in Fig. 1 . The amount of K-26 produced increased after the growth of cells reached the maximum. The effect of natural nitrogen sources, the concentration of phosphate and amino acids added on the production of K-26 was investigated. Corn steep liquor at the concentration of 0.5, 1 and 2 % stimulated the production, but repressed it at 5 % or when used in combination with 3 % soy bean meal (Table 1 -A, B). K-26 production was remarkably affected by phosphate concentration. The optimum concentration of phosphate for the production was 0.05Y. as shown in Fig. 2 . The effect of amino acids is summarized in Table 2 . The addition of serine at 0.5 % slightly increased the amount of K-26 produced while other amino acids tested had no effect or decreased it. 
K2HP04
(o) SBM (3%) plus CSL (0.5y.) in the control medium were replaced by 2 % of various natural nitrogen sources (Table 1-A) and by SBM (3%) plus CSL (0, 1, 2,5%) or CSL alone (0.5, 1, 2,5%) ( Table 1-B) .
The incubation was carried out in the same way as described in Materials and Methods. Amino acids were added at 0.5% to the production medium. The incubation was carried out in the same way as described in Materials and Methods. 
Physico-chemical Properties
Physico-chemical properties are represented in Table 3 . K-26 is a water soluble, acidic substance which is positive to Rydon-Smith and iodine but negative to ninhydrin and all other color reactions tested. The IR spectrum of K-26 suggests the presence of amide group in its structure (Fig. 4) . The UV spectrum was quite identical to that of tyrosine. Acid hydrolysis of K-26 with 6 N HCl at 110°C for 16 hours gave isoleucine, tyrosine and an unknown ninhydrin-positive compound (Fig. 5) . Amino acid analysis of the acid hydrolysate revealed that the molar ratio of isoleucine and tyrosine was 1: 1 and that the unknown compound was eluted between serine and glutamic acid (the data not shown here). It is clear from these results that the unknown compound is different from proline and any other natural amino acids. The structure of the unknown compound was deduced to be 1(R)-1-amino-2-(4-hydroxyphenyl)ethylphosphonic acid. Isoleucine and tyrosine were found to have L-configuration. The molar ratio of three components was determined to be 1: 1: 1. The DNP-derivative of K-26 was not obtained, suggesting that the N-terminal was modified. The C-terminal residue was determined to be 1-amino-2-(4-hydroxyphenyl)ethylphosphonic acid by the hydrazinolysis of K-26.
Details of these studies will be described in a separate paper".
Biochemical Properties
ACE inhibitory activity in vitro of K-26, together with that of captopril, is shown in Table 4 .
When HHL was used as a substrate, IC,, values were 6.7 ng/ml in a phosphate buffer and 12 ng/ml in a borate buffer. When AG I was a substrate, the IC,, was 3.3 ng/ml. K-26 proves to be just as potent as captopril in ACE inhibition in vitro. Table 5 shows the inhibitory activity of K-26 against some proteases. At the concentration of 33 pg/ml which is 5,000 times higher than the IC50 of K-26
for ACE inhibition, this compound inhibited carboxypeptidase A only slightly but did not inhibit other proteases (carboxypeptidase B, a-chymotrypsin and trypsin) at all, implying that K-26 is a specific inhibitor of ACE. K-26 was not hydrolyzed by any of the proteases so far tested (carboxypeptidases A and B, trypsin, a-chymotrypsin, leucine aminopeptidase, pronase, pepsin, papain, thermolysin and substilisin).
Kinetics of ACE Inhibition by K-26 The kinetic study was carried out with purified ACE in 0.1 M borate buffer, pH 8.3, HHL being Six determinations were made to obtain an IC50. The average values were represented here. 
Biological Activity
The biological activity in vivo of K-26 was determined with captopril as a control.
In an an- esthetized, normotensive rat, the pressor response to AG I was antagonized completely and specifically by K-26 administered intravenously at a dose of 0.1 mg/kg (Fig. 7) . The pressor response to AG II or noradrenaline was not inhibited at all. The dose dependence and duration of the inhibition by K-26 of the pressor response to AG I was investigated also in an anesthetized, normotensive rat. K-26, administered intravenously at 0.01 to 0.1 mg/kg, showed the same degree of inhibition and duration as those of captopril (Fig. 8) .
Discussion
Several microbial inhibitors of ACE have been reported recently. They include aspergillomarasmines11), muraceins12), L-681,17613), 15B214), A58365A, B11), ancovenin18) and talopeptin17). They are peptides or peptide-like compounds except that A58365A and B are bicyclic dicarboxylic acids. Some of them have considerable ACE inhibitory activity, but others are less potent as ACE inhibitors. K-26 is a new member of microbial ACE inhibitors and possesses the highest inhibitory activity in vitro among them, being comparable to captopril. K-26 is unique in following respects. 1) It does not contain a proline residue which has been reported to be essential for the interaction of an inhibitor with ACED and is a structural component of almost all potent inhibitors of ACE. Nevertheless, it is highly active against ACE in vitro as described above. 2) It contains an unusual aminophosphonic acid, I-amino-2-(4-hydroxyphenyl)ethylphosphonic acid. The phosphonic moiety of this compound may act as the ligand for the active site zinc ion on ACE.
3) It inhibited ACE non-competitively with respect to HHL whereas captopril and most others inhibited ACE competitively. There are only a few non-competitive inhibitors of ACE so far reported, among which are K-410), NI-phosphoryl-LAla-L-Pro, Na-phosphoryl-L-Val-L-Trp20), a ketomethylene tripeptide analogue2l) and ACTH related peptides L2). Kinetic studies of these inhibitors were carried out primarily with HHL used as a substrate. However, both of N1 phosphoryl dipeptides and a ketomethylene tripeptide analogue were reported to behave as competitive inhibitors of ACE when AG I was used as a substrate 20, 21) . It is possible that K-26 also inhibits ACE competitively with respect to AG I. Anyway, details on the mechanism of ACE inhibition remain to be clarified. As for the biological activity, K-26, intravenously administered, antagonized completely and specifically the pressor response to AG I in an anesthetized, normotensive rat.
It is interesting that a soil microorganism produces a potent ACE inhibitor like K-26. There may be a good chance of getting clinically useful inhibitors of ACE by the screening of microorganism as well as by chemical synthesis. 
